Advertisement
U.S. markets open in 8 hours 54 minutes
Advertisement

NGM Biopharmaceuticals, Inc. (NGM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.7950+0.0256 (+3.33%)
At close: 04:00PM EST
0.8400 +0.05 (+5.66%)
After hours: 07:20PM EST
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts5455
Avg. Estimate-0.39-0.36-1.79-1.2
Low Estimate-0.66-0.48-2.08-1.63
High Estimate-0.31-0.29-1.7-0.55
Year Ago EPS-0.45-0.58-2.03-1.79
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts4355
Avg. Estimate620k250k4.83M220k
Low EstimateN/AN/A4.25MN/A
High Estimate2M500k6.25M500k
Year Ago Sales18.18MN/A55.33M4.83M
Sales Growth (year/est)-96.60%N/A-91.30%-95.40%
Earnings History12/30/20223/30/20236/29/20239/29/2023
EPS Est.-0.51-0.52-0.5-0.42
EPS Actual-0.45-0.58-0.46-0.35
Difference0.06-0.060.040.07
Surprise %11.80%-11.50%8.00%16.70%
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate-0.39-0.36-1.79-1.2
7 Days Ago-0.39-0.36-1.79-1.2
30 Days Ago-0.42-0.41-1.9-1.46
60 Days Ago-0.42-0.41-1.9-1.46
90 Days Ago-0.44-0.45-1.91-1.68
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3244
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNGMIndustrySector(s)S&P 500
Current Qtr.13.30%N/AN/AN/A
Next Qtr.37.90%N/AN/AN/A
Current Year11.80%N/AN/AN/A
Next Year33.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A